Lion Bufferin Premium 20402 is a specialized pharmaceutical formulation designed for rapid symptom mitigation in demanding clinical contexts. This product combines buffering agents with active pharmaceutical ingredients to support consistent absorption and patient comfort.
Manufactured under strict quality controls, Lion Bufferin Premium 20402 targets healthcare professionals who require reliable performance in acute care environments. The following sections outline core specifications, dosing logic, and operational considerations for this premium offering.
| Attribute | Specification | Unit | Reference Standard |
|---|---|---|---|
| Active Ingredient | Acetylsalicylic Acid | mg | USP Monograph |
| Buffer System | Aluminum and Magnesium Carbonates | mg | Pharmacopeial Buffer Profile |
| Coating Type | Enteric Film | — | Enteric Release Criteria |
| Target Release pH | 5.5–7.0 | unitless | In vitro Dissolution Guidelines |
| Pack Size | 20 Tablets | units | Commercial SKU 20402 |
Formulation Chemistry and Stability
Chemical Profile
Lion Bufferin Premium 20402 relies on a buffered aspirin matrix that minimizes gastric irritation while preserving therapeutic efficacy. The buffering system modulates acid load, supporting controlled solubility in gastric and intestinal media.
Shelf Life Indicators
Under defined storage conditions, the product maintains assay purity and compliance with labeled claims through the stated expiration period. Stability testing confirms consistent performance across varied temperature and humidity scenarios.
Clinical Dosing and Administration
Prescribers utilize Lion Bufferin Premium 20402 to address acute pain and inflammatory states where rapid onset is clinically advantageous. Standard dosing protocols emphasize adherence to recommended unit quantities to balance efficacy and safety margins.
Healthcare teams appreciate the uniform tablet configuration, which supports accurate measurement and reduces administration variability in both inpatient and outpatient settings.
Safety, Compliance, and Regulatory Considerations
Labeling and Indication Scope
Regulatory authorities classify this product under established analgesic and anti-inflammatory guidelines. Clear labeling supports appropriate use and aligns with institutional formulary requirements.
Adverse Event Monitoring
Pharmacovigilance data indicate a manageable safety profile when product directions are followed, with emphasis on contraindication screening and risk minimization strategies in at-risk populations.
Operational Logistics and Supply Chain Integration
Procurement professionals value Lion Bufferin Premium 20402 for its predictable availability and standardized packaging formats that integrate with automated dispensing systems. Inventory management protocols ensure optimal stock levels while mitigating expiration-related wastage.
Implementation and Best Practices
- Verify patient-specific contraindications prior to dispensing.
- Coordinate with pharmacy to ensure buffer system compatibility with concurrent therapies.
- Monitor therapeutic response using validated pain and inflammation scales.
- Document lot numbers and expiration dates in inventory systems to support traceability.
FAQ
Reader questions
What clinical scenarios is Lion Bufferin Premium 20402 preferred over unbuffered aspirin?
It is favored in settings where minimizing gastric irritation is critical, such as in patients with a history of peptic ulcer disease or those requiring extended absorption windows in acute care.
How does the enteric coating affect onset of action compared to standard aspirin?
The enteric film delays dissolution until intestinal pH, which may slightly delay peak plasma levels while reducing direct gastric irritation, providing a balanced approach for scheduled dosing.
Are there specific patient populations that require adjusted dosing schedules?
Yes, individuals with hepatic impairment, renal dysfunction, or those on concurrent anticoagulant therapy should be monitored closely, and dosing adjustments should follow prescriber guidance and institutional protocols.
What storage conditions are required to maintain product stability?
Store at controlled room temperature, protected from excessive moisture and light, and maintain packaging integrity to ensure the buffer system and active ingredient remain within approved specifications until the labeled expiration date.